Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Fanikos

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
The American Journal of Medicine|May 5, 2020
Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action InitiativeEbrahim Barkoudah, Gregory Piazza, Todd E H Hecht, et al.
JAMA|September 15, 2025
Superficial Vein Thrombosis: A ReviewGregory Piazza, Darsiya Krishnathasan, Nada Hamade, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2006
Venous thromboembolic disease. Clinical practice guidelines in oncologyLawrence D Wagman, Melissa F Baird, Charles L Bennett, et al.
The American Journal of Medicine|May 29, 2023
Anticoagulation-Associated Adverse Drug Events in Hospitalized Patients Across Two Time PeriodsJohn Fanikos, Yahya Tawfik, Danya Almheiri, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 18, 2008
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncologyLawrence D Wagman, Melissa F Baird, Charles L Bennett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 1, 2011
Venous thromboembolic diseaseMichael B Streiff, Paula L Bockenstedt, Spero R Cataland, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2013
Venous thromboembolic diseaseMichael B Streiff, Paula L Bockenstedt, Spero R Cataland, et al.
Medrxiv : the Preprint Server for Health Sciences|May 11, 2021
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized TrialsAzita H Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
Journal of the American College of Cardiology|October 15, 2021
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art ReviewAzita H Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
Contemporary Clinical Trials|May 1, 2021
The Pharmacist Discharge Care (PHARM-DC) study: A multicenter RCT of pharmacist-directed transitional care to reduce post-hospitalization utilizationJoshua M Pevnick, Michelle S Keller, Korey A Kennelty, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
The American Journal of Medicine|May 5, 2020
Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action InitiativeEbrahim Barkoudah, Gregory Piazza, Todd E H Hecht, et al.
JAMA|September 15, 2025
Superficial Vein Thrombosis: A ReviewGregory Piazza, Darsiya Krishnathasan, Nada Hamade, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2006
Venous thromboembolic disease. Clinical practice guidelines in oncologyLawrence D Wagman, Melissa F Baird, Charles L Bennett, et al.
The American Journal of Medicine|May 29, 2023
Anticoagulation-Associated Adverse Drug Events in Hospitalized Patients Across Two Time PeriodsJohn Fanikos, Yahya Tawfik, Danya Almheiri, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 18, 2008
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncologyLawrence D Wagman, Melissa F Baird, Charles L Bennett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 1, 2011
Venous thromboembolic diseaseMichael B Streiff, Paula L Bockenstedt, Spero R Cataland, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2013
Venous thromboembolic diseaseMichael B Streiff, Paula L Bockenstedt, Spero R Cataland, et al.
Medrxiv : the Preprint Server for Health Sciences|May 11, 2021
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized TrialsAzita H Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
Journal of the American College of Cardiology|October 15, 2021
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art ReviewAzita H Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
Contemporary Clinical Trials|May 1, 2021
The Pharmacist Discharge Care (PHARM-DC) study: A multicenter RCT of pharmacist-directed transitional care to reduce post-hospitalization utilizationJoshua M Pevnick, Michelle S Keller, Korey A Kennelty, et al.
Pageof 15